158 related articles for article (PubMed ID: 8570770)
1. Decreased urinary peptide excretion in schizophrenic patients after neuroleptic treatment.
Reichelt KL; Teigland-Gjerstad B
Psychiatry Res; 1995 Sep; 58(2):171-6. PubMed ID: 8570770
[TBL] [Abstract][Full Text] [Related]
2. Neuroleptic dose reduction for schizophrenic outpatients: a three-year follow-up study.
Faraone SV; Cirelli V; Curran JP; Brown WA
Hosp Community Psychiatry; 1988 Nov; 39(11):1207-8. PubMed ID: 2906321
[No Abstract] [Full Text] [Related]
3. Symptoms in neuroleptic-naive, first-episode schizophrenia: response to risperidone.
Kopala LC; Fredrikson D; Good KP; Honer WG
Biol Psychiatry; 1996 Feb; 39(4):296-8. PubMed ID: 8645777
[No Abstract] [Full Text] [Related]
4. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.
Szymanski S; Lieberman J; Pollack S; Kane JM; Safferman A; Munne R; Umbricht D; Woerner M; Masiar S; Kronig M
Biol Psychiatry; 1996 Feb; 39(4):249-54. PubMed ID: 8645771
[TBL] [Abstract][Full Text] [Related]
5. Depot neuroleptic therapy: clinical considerations.
Remington GJ; Adams ME
Can J Psychiatry; 1995 Apr; 40(3 Suppl 1):S5-11. PubMed ID: 7627927
[TBL] [Abstract][Full Text] [Related]
6. Study of the clinical utility of radioreceptor assay in outpatients with schizophrenia receiving high doses of neuroleptics.
Gagné MA; Cormier H; Leblanc G; Lévesque D; Di Paolo T
Can J Psychiatry; 1993 Oct; 38(8):534-40. PubMed ID: 7902199
[TBL] [Abstract][Full Text] [Related]
7. [The "neuroleptic threshold"--a review of the literature].
Abraham D; Kissling W; Lauter H
Psychiatr Prax; 1996 May; 23(3):109-16. PubMed ID: 8710999
[TBL] [Abstract][Full Text] [Related]
8. Neuroleptic dosing in chronic schizophrenia: a 10-year follow-up.
Remington GJ; Prendergast P; Bezchlibnyk-Butler KZ
Can J Psychiatry; 1997 Feb; 42(1):53-7. PubMed ID: 9040924
[TBL] [Abstract][Full Text] [Related]
9. Prolactin shifts after neuroleptic withdrawal.
Green AI; Faraone SV; Brown WA
Psychiatry Res; 1990 Jun; 32(3):213-9. PubMed ID: 1975101
[TBL] [Abstract][Full Text] [Related]
10. Effects of neuroleptic reduction in schizophrenic outpatients receiving high doses.
Leblanc G; Cormier H; Gagné MA; Vaillancourt S
Can J Psychiatry; 1994 May; 39(4):223-9. PubMed ID: 7913872
[TBL] [Abstract][Full Text] [Related]
11. Increments in plasma homovanillic acid concentrations after neuroleptic discontinuation are associated with worsening of schizophrenic symptoms.
Khan RS; Amin F; Powchik P; Knott P; Goldstein M; Apter S; Kerman B; Jaff S; Davidson M
Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(6):879-84. PubMed ID: 1980541
[TBL] [Abstract][Full Text] [Related]
12. Neuroleptic dosing and neuroleptic plasma levels in schizophrenia: determining the optimal regimen.
Shriqui CL
Can J Psychiatry; 1995 Sep; 40(7 Suppl 2):S38-48. PubMed ID: 8564916
[TBL] [Abstract][Full Text] [Related]
13. Tardive dyskinesia in the mentally retarded: comparison of prevalence, risk factors and topography with a schizophrenic population.
Cohen S; Khan A; Zheng Y; Chiles J
Acta Psychiatr Scand; 1991 Mar; 83(3):234-7. PubMed ID: 1674398
[TBL] [Abstract][Full Text] [Related]
14. Neuroleptic-induced emesis: a new indication for clozapine?
Bustillo JR; Buchanan RW
Biol Psychiatry; 1995 Aug; 38(3):194-5. PubMed ID: 7578665
[No Abstract] [Full Text] [Related]
15. Serum neuroleptic levels, prolactin levels, and relapse: a two-year study of schizophrenic outpatients.
Faraone SV; Brown WA; Laughren TP
J Clin Psychiatry; 1987 Apr; 48(4):151-4. PubMed ID: 2881923
[TBL] [Abstract][Full Text] [Related]
16. Self-reported prescribing practices for schizophrenic patients among Israeli psychiatrists.
Heresco-Levy U; Brom D; Greenberg D
Isr J Psychiatry Relat Sci; 1993; 30(3):164-74. PubMed ID: 7901179
[TBL] [Abstract][Full Text] [Related]
17. Electroconvulsive therapy in neuroleptic-induced parkinsonism.
Goswami U; Dutta S; Kuruvilla K; Papp E; Perenyi A
Biol Psychiatry; 1989 Jul; 26(3):234-8. PubMed ID: 2568133
[TBL] [Abstract][Full Text] [Related]
18. [Patient modified medication: how do schizophrenic patients manage their neuroleptics?].
Hornung WP; Buchkremer G; Redbrake M; Klingberg S
Nervenarzt; 1993 Jul; 64(7):434-9. PubMed ID: 8103569
[TBL] [Abstract][Full Text] [Related]
19. Lower-dose therapy with traditional neuroleptics in chronically hospitalized schizophrenic patients.
Smith RC
Arch Gen Psychiatry; 1994 May; 51(5):427-9. PubMed ID: 7910013
[No Abstract] [Full Text] [Related]
20. Treatment of late-life schizophrenia with neuroleptics.
Jeste DV; Lacro JP; Gilbert PL; Kline J; Kline N
Schizophr Bull; 1993; 19(4):817-30. PubMed ID: 7905663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
